Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Although anti-inflammatory drugs have shown promising results in preclinical cardiovascular research, they have yielded little benefit in clinical trials. Before we can expect positive outcomes, we need to find ways of stratifying patients based on their infectious, inflammatory and autoimmune profile, and identify the right time of treatment.
The European Research Council (ERC) provides opportunities each year for researchers to apply for various grant programs to fund their research. One of these grant categories is the ERC Starting Grant, which is specifically designed for early-career scientists who are prepared to work independently. This grant is open to researchers from any field and any nationality provided that they have 2–7 years of experience since completing their PhD and are conducting their research at public or private research organizations in EU member states or associated countries. The competition for this prestigious funding opportunity is fierce, but successful projects can receive up to €1.5 million for a period of 5 years.
In the USA, scientific merit is the main criterion determining funding for biomedical research, but not for the institutional space or support needed to perform it. Realigning the incentives of academic institutions with those of funding sources could produce better science.
The European Research Council (ERC) provides opportunities each year for researchers to apply for various grant programs to fund their research. One of these grant categories is the ERC Starting Grant, which is specifically designed for early-career scientists who are prepared to work independently. This grant is open to researchers from any field and any nationality provided that they have 2–7 years of experience since completing their PhD and are conducting their research in public or private research organizations in EU member states or associated countries. The competition for this prestigious funding opportunity is fierce, but successful projects can receive up to €1.5 million for a period of 5 years.
The European Research Council (ERC) provides opportunities each year for researchers to apply for various grant programs to fund their research. One of these grant categories is the ERC Starting Grant, which is specifically designed for early-career scientists who are prepared to work independently. This grant is open to researchers from any field and any nationality provided that they have 2–7 years of experience since completing their PhD and are conducting their research at public or private research organizations in EU member states or associated countries. The competition for this prestigious funding opportunity is fierce, but successful projects can receive up to €1.5 million for a period of 5 years.
The European Research Council (ERC) provides opportunities each year for researchers to apply for various grant program to fund their research. One of these grant categories is the ERC Starting Grant, which is specifically designed for early-career scientists who are prepared to work independently. This grant is open to researchers from any field and any nationality provided that they have 2–7 years of experience since completing their PhD and are conducting their research in public or private research organizations in EU member states or associated countries. The competition for this prestigious funding opportunity is fierce, but successful projects can receive up to €1.5 million for a period of 5 years.
The Leducq Foundation is a not-for-profit grant-making organization that has been fostering transatlantic collaboration in the cardiovascular field for two decades. Here we learn more about the history of the foundation, its ongoing projects, and its impacts on the cardiovascular field in conversation with David Tancredi, who has had an executive role with the Leducq organization for over 20 years, and with Connie R. Bezzina and Mete Civelek, who are coordinators of two financed networks of excellence.